EVOLUS, INC. Basic Shares Outstanding (Weighted Average)
EVOLUS, INC. (EOLS) reported Basic Shares Outstanding (Weighted Average) of 65.93 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- EVOLUS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 65.93M shares, a 2.15% increase year-over-year.
- EVOLUS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 65.19M shares, a 2.34% increase year-over-year.
- EVOLUS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 64.90M shares, a 2.40% increase year-over-year.
- EVOLUS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 64.73M shares, a 2.50% increase year-over-year.
- EVOLUS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 64.47M shares, a 3.95% increase from fiscal 2024.
- EVOLUS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 62.02M shares, a 8.96% increase from fiscal 2023.
- EVOLUS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 56.92M shares, a 1.52% increase from fiscal 2022.
- EVOLUS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 56.07M shares, a 12.64% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 65.93M shares 10-Q · filed 2026-08-05 | 65.56M shares 10-Q · filed 2026-08-05 | 65.34M shares derived: average of 3 quarters · filed 2026-08-05 | 65.19M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 65.19M shares 10-Q · filed 2026-05-04 | 65.04M shares derived: average of 2 quarters · filed 2026-05-04 | 64.94M shares derived: average of 3 quarters · filed 2026-05-04 | 64.84M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 64.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 64.81M shares derived: average of 2 quarters · filed 2026-03-03 | 64.72M shares derived: average of 3 quarters · filed 2026-08-05 | 64.47M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 64.73M shares 10-Q · filed 2025-11-05 | 64.63M shares derived: average of 2 quarters · filed 2026-08-05 | 64.32M shares 10-Q · filed 2025-11-05 | 64.09M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 64.54M shares 10-Q · filed 2026-08-05 | 64.12M shares 10-Q · filed 2026-08-05 | 63.87M shares derived: average of 3 quarters · filed 2026-08-05 | 63.69M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 63.70M shares 10-Q · filed 2026-05-04 | 63.54M shares derived: average of 2 quarters · filed 2026-05-04 | 63.41M shares derived: average of 3 quarters · filed 2026-05-04 | 63.24M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 63.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 63.26M shares derived: average of 2 quarters · filed 2026-03-03 | 63.08M shares derived: average of 3 quarters · filed 2026-03-03 | 62.02M shares 10-K · filed 2026-03-03 |
| 2024-09-30 | 63.15M shares 10-Q · filed 2025-11-05 | 62.94M shares derived: average of 2 quarters · filed 2025-11-05 | 61.56M shares 10-Q · filed 2025-11-05 | 60.48M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | 62.72M shares 10-Q · filed 2025-08-05 | 60.76M shares 10-Q · filed 2025-08-05 | 59.59M shares derived: average of 3 quarters · filed 2026-03-03 | 58.95M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | 58.80M shares 10-Q · filed 2025-05-07 | 58.02M shares derived: average of 2 quarters · filed 2026-03-03 | 57.69M shares derived: average of 3 quarters · filed 2026-03-03 | 57.50M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | 57.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 57.14M shares derived: average of 2 quarters · filed 2026-03-03 | 57.06M shares derived: average of 3 quarters · filed 2026-03-03 | 56.92M shares 10-K · filed 2026-03-03 |
| 2023-09-30 | 57.02M shares 10-Q · filed 2024-11-06 | 56.97M shares derived: average of 2 quarters · filed 2024-11-06 | 56.81M shares 10-Q · filed 2024-11-06 | 56.67M shares derived: average of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | 56.92M shares 10-Q · filed 2024-07-31 | 56.70M shares 10-Q · filed 2024-07-31 | 56.55M shares derived: average of 3 quarters · filed 2025-03-04 | 56.46M shares derived: average of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | 56.48M shares 10-Q · filed 2024-05-07 | 56.37M shares derived: average of 2 quarters · filed 2025-03-04 | 56.31M shares derived: average of 3 quarters · filed 2025-03-04 | 56.25M shares derived: average of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | 56.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 56.22M shares derived: average of 2 quarters · filed 2025-03-04 | 56.18M shares derived: average of 3 quarters · filed 2025-03-04 | 56.07M shares 10-K · filed 2025-03-04 |
| 2022-09-30 | 56.18M shares 10-Q · filed 2023-11-07 | 56.13M shares derived: average of 2 quarters · filed 2023-11-07 | 56.00M shares 10-Q · filed 2023-11-07 | 55.91M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 56.08M shares 10-Q · filed 2023-08-02 | 55.91M shares 10-Q · filed 2023-08-02 | 55.82M shares derived: average of 3 quarters · filed 2023-08-02 | 55.61M shares derived: average of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | 55.73M shares 10-Q · filed 2023-05-09 | 55.68M shares derived: average of 2 quarters · filed 2023-05-09 | 55.46M shares derived: average of 3 quarters · filed 2023-05-09 | 54.38M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 55.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 55.32M shares derived: average of 2 quarters · filed 2023-03-08 | 53.93M shares derived: average of 3 quarters · filed 2023-03-08 | 49.77M shares 10-K · filed 2023-03-08 |
| 2021-09-30 | 55.01M shares 10-Q · filed 2022-11-08 | 53.08M shares derived: average of 2 quarters · filed 2022-11-08 | 47.82M shares 10-Q · filed 2022-11-08 | 44.25M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 51.15M shares 10-Q · filed 2022-08-02 | 44.16M shares 10-Q · filed 2022-08-02 | 40.67M shares derived: average of 3 quarters · filed 2022-08-02 | 38.94M shares derived: average of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | 37.10M shares 10-Q · filed 2022-05-10 | 35.43M shares derived: average of 2 quarters · filed 2022-05-10 | 34.87M shares derived: average of 3 quarters · filed 2022-05-10 | 34.58M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 33.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 33.75M shares derived: average of 2 quarters · filed 2022-03-03 | 33.74M shares derived: average of 3 quarters · filed 2022-03-03 | 33.74M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 33.75M shares 10-Q · filed 2021-11-02 | 33.74M shares derived: average of 2 quarters · filed 2021-11-02 | 33.73M shares 10-Q · filed 2021-11-02 | |
| 2020-06-30 | 33.73M shares 10-Q · filed 2021-08-04 | 33.73M shares 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | 33.72M shares 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |